Effect of VR Versus CT in Sensorimotor Function of Upper Extremity in Chronic Stroke Patients

NAActive, not recruitingINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

July 1, 2024

Study Completion Date

October 30, 2024

Conditions
Chronic Stroke
Interventions
COMBINATION_PRODUCT

Virtual Reality (VR) Therapy

"Intervention: Patients in this group will receive therapy using VR technology. This involves engaging in various sensorimotor training exercises and tasks in an immersive virtual environment. The VR sessions are designed to be interactive and adaptive, providing real-time feedback to the user. The exercises will target the improvement of motor functions, coordination, and strength of the affected upper extremity.~Duration and Frequency: The specific regimen may involve sessions several times a week, with each session lasting between 30 to 60 minutes, over a period of several weeks or months, depending on the study design."

DIAGNOSTIC_TEST

Conservative Treatment

"Intervention: Patients in this group will receive traditional rehabilitation therapies, which may include:~Physical Therapy (PT): Exercises and activities aimed at improving strength, flexibility, and coordination of the upper limb.~Occupational Therapy (OT): Functional task training to enhance daily living skills and independence, focusing on the use of the upper extremity.~Manual Therapy: Techniques such as massage or joint manipulation to improve mobility and reduce pain.~Home Exercise Programs: Prescribed exercises to be performed at home to reinforce therapy sessions.~Duration and Frequency: Similar to the VR group, this regimen may involve regular sessions several times a week, with each session lasting between 30 to 60 minutes, over a comparable period."

Trial Locations (1)

Unknown

Services Hospital,Shadman 1, Lahore

All Listed Sponsors
lead

Superior University

OTHER

NCT06568874 - Effect of VR Versus CT in Sensorimotor Function of Upper Extremity in Chronic Stroke Patients | Biotech Hunter | Biotech Hunter